Information  X 
Enter a valid email address

Andrews Sykes Group (ASY)

  Print      Mail a friend

Friday 01 June, 2018

Andrews Sykes Group

Transaction in Own Shares

RNS Number : 9155P
Andrews Sykes Group PLC
01 June 2018
 

Andrews Sykes Group PLC

("Andrews Sykes" or the "Company")

Transaction in Own Shares

Andrews Sykes announces that, on 31 May 2018, it re-purchased 87,723 ordinary shares of one pence each in the capital of the Company ("Ordinary Shares") at a price of 494 pence per Ordinary Share (the "Re-Purchase").

 

The Re-Purchase equates to approximately 0.2 per cent. of the issued Ordinary Shares and was undertaken in accordance with the terms of the general authority to make market purchases of Ordinary Shares granted to the Company by its shareholders at its Annual General meeting on 21 June 2017.

 

The Re-Purchase was executed on the London Stock Exchange through the Company's broker, Arden Partners.

 

The Ordinary Shares the subject of the Re-Purchase shares will be cancelled with immediate effect (the "Cancellation").

 

Following the Re-Purchase and the Cancellation, the number of issued Ordinary Shares with voting rights in the Company is 42,174,359. This figure represents the total voting rights in the Company and may be used by shareholders as the denominator for the calculations by which they can determine if they are required to notify their interest in, or a change to their interest in the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

The Company does not hold any Ordinary Shares in Treasury.

Enquiries:

 

Andrews Sykes Group plc

+44 (0)1902 328 700

Mark Calderbank


 

GCA Altium (Nominated Adviser)

 

+44 (0)207 484 4040

Tim Richardson


 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
POSLLFEEEEILVIT

a d v e r t i s e m e n t